CardioRenal Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 75.4% | 0.856 | Q1 | 79.5% |
| 2024 | 2.9 | Q2 | 75.4% | 0.723 | Q2 | 74.6% |
| 2023 | 2.4 | Q2 | 64.3% | 0.758 | Q1 | 78.1% |
| 2022 | 3.8 | Q1 | 83.2% | 0.705 | Q2 | 77.0% |
| 2021 | 4.4 | Q2 | 81.5% | 0.600 | Q2 | 72.9% |
| 2020 | — | — | 0.661 | Q2 | 74.6% | |
| 2019 | — | — | 0.804 | Q2 | 80.5% | |
| 2018 | — | — | 0.880 | Q1 | 81.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1664-3828
ISSN
1664-5502
region
Western Europe
coverage
2011-2026